Somaiya Mayur Ian sold NAMS

January 5, 2026 · Form 4 insider transaction

Somaiya Mayur Ian sold 5,118 shares of NewAmsterdam Pharma Company N.V. at $33.25 per share, a transaction worth $170.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
5,118
Price
$33.25
Total value
$170.2K
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after32,882
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents pre-arranged sale of shares by the Reporting Person solely to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) pursuant to sell-to-cover agreement entered into with the Issuer. The sale does not represent a discretionary transaction by the Reporting Person.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.77 to $33.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.

View the original Form 4 on SEC EDGAR